The pharmaceutical sector in India employs nearly 2.8 million people.
Gender inclusivity in areas such as sales, technical work, manufacturing, and production remains at a growth of 15% as businesses are made more conducive and safe.
Research and Developement
Application Programming Interface (API)
Machine Learning
Internet of Things (IoT)
Cloud and Cybersecurity
Regulations and Compliance
Head of HR - Global Operations, India -
Emerging Asia and Access Markets, Viatris
Pharma has been the only sector during the pandemic that was running to the capacity in terms of supply, manufacturing and developing drugs. The Pharmaceutical industry in India is currently valued at USD 41.7 bn and is expected to reach USD 65 bn by 2024 and to USD 120 bn by 2030 .The opportunities and the talent available in this sector are constantly growing.” Udbhav Ganjoo, Head of HR – Global Operations ,India ,Emerging Asia and Access Markets - Viatris
President & Global HR Head,
Macleods Pharma
Our hiring is on an upswing. After the second wave, the pharma industry portfolio has started growing rapidly. As the market opened, people have started working now and businesses have bounced back. During this pandemic India has become the manufacturing hub, most companies are finding ways to fulfill this demand supply gap globally. Companies are required to expand the international business along with catering to the domestic market. Organizations required to work on development of the talent pool for sustaining the growth trajectory.
Group Chief People Officer,
Akums Drugs
In India the healthcare industry is going to be USD 350+ Billion in the next one year. The government of India is focussing on increasing the spending on healthcare to 50% of GDP. We should focus on four major pillars - one is strengthening talent through regular skilling, second is building inclusivity, third is creating a good employee experience, and the fourth important element is onboard new talent.
Head HR, Roche
Head of HR & Administration, Aurigene Services
Head People and Performance, Apotex
Global TA, Indegene